[12:15 am, 01/10/2026] huai2: Whats' the update on this patient please?
[7:36 am, 01/10/2026] cm: A new PaJR group has been created for him and the discussions have shifted there.
[8:32 pm, 03/10/2026] cm: In 1973, eight perfectly healthy people walked into psychiatric hospitals across the United States.
None of them were ill.
No one inside realized it. ðŸ§
This was not an accident.
It was an experiment designed by psychologist David Rosenhan to answer a disturbing question.
Can professionals reliably tell the difference between mental health and mental illness?
To find out, Rosenhan recruited eight ordinary people. A painter. A housewife. A pediatrician. A graduate student.
They lied about only one thing. They said they heard voices. Just three words. “Empty.” “Hollow.” “Thud.”
That was enough.
All eight were admitted.
The moment they entered the hospitals, they stopped pretending. They behaved normally. They cooperated. They asked to be discharged. 🚪
It never worked.
Every normal action was reinterpreted as a symptom.
Writing notes became obsessive behavior.
Waiting quietly became pathological attention seeking.
Politeness became controlled behavior consistent with illness.
Seven were diagnosed with schizophrenia.
One with manic depression.
Not a single staff member identified them as healthy.
But the patients did.
Real patients approached them and whispered, “You’re not like the others. You don’t belong here.”
Those considered ill saw what trained professionals could not.
The average stay was 19 days.
One person remained hospitalized for 52 days. ⏳
Each day reinforced the same truth. Once labeled, reality stopped mattering.
When Rosenhan published On Being Sane in Insane Places, the psychiatric world erupted. One hospital challenged him to send new pseudopatients, confident they would catch them.
Rosenhan agreed.
Over the next months, that hospital identified 41 supposed impostors.
Rosenhan had sent no one. Not a single person.
The conclusion was unavoidable.
Diagnosis was not always based on facts. It was shaped by context and expectation.
This experiment shattered blind trust in clinical labels and forced major changes in how mental illness is diagnosed and treated. But its deeper lesson still unsettles today.
Perception can distort reality more than madness itself.
And sometimes, the most dangerous illusion belongs to those who believe they cannot be wrong.
#psychology #history #mentalhealth #science #reality #humanrights #truth #viralpost
[8.44 pm, 1/10/2026] huai10: 😳 Imagine what happens to healthcare under NMC and Rehabilitation under RCI - Both run by administrators and not technocrats 🥴
[8:00 am, 13/10/2026] cm: Gemini helped to make this idea into a full paper!
Since last two years we had been toying with the idea that AI agents would one day be able to go through our project data archived in online repositories and write a paper utilising that data and today appears to have been that day!
One can't be very sure about AI's credibility although to us it appears impressive but it's possible there are hidden hallucinatory assumptions other than obvious mathematical formatting issues.
Interestingly the paper was precipitated by a chance dyadic discussion around a veritasium video linked inside the text of the paper here 👇
[8:41 am, 13/10/2026] cm: OPD now
What a machine cannot do for you:
Look back at the seven purposes and notice what they have in common. None of them can be delivered. Judgment, perspective, character, the ability to learn, a sense of direction and the capacity to live alongside people unlike oneself are not things a professor can hand over, or a student can download. They grow only through practice: by attempting hard things, getting them wrong, hearing honest feedback and trying again, in the company of others.
That is why AI, for all it can do, cannot do any of these things on a student’s behalf. And that, I think, is the answer to the question that keeps me up at night. A university in the age of AI is for forming people who can think, judge and learn for themselves, and who have practised doing so under real conditions.
Staff CPC (14/10/2026) - Clinical Potocol
Name: PD, Age/Sex: 38yr / Female Residence: Kangra, HP Clinician in-charge: Prof. Sanjay Jain CR. No: 201001869018 Ward: FMW Clinical discussant: Dr. Shankar Naidu Ad. No: 2026014318 DOA: 17-02-2026 Radiology discussant: Dr. Mansi Verma DOD: 21-02-2026 Pathology discussant: Prof. Amanjit Bal Chief Complaints: Progressive dysphagia x 3 months Worsening of breathlessness x 1month Background History: Symptomatic since 1999, Raynaud’s involving all fingers and toes, initially only during winters, since 2008, episodes of RP started to occur even during warmer months. a/w fingertip ulcers, healing with scars. No h/o gangrene of digits. In 2008, noticed skin tightness over hands and face, a/w pruritus and edema of involved areas. Subsequently, tightness progressed to involve forearms, arms, chest and abdomen. Skin tightness of hands worsened such that she had restriction in movements of small joints of hands and was unable to grip objects in hands. H/o retrosternal burning sensation and reflux of gastric contents present. Since 2009, developed breathlessness, insidious onset, progressive (mMRC I to II over 1 year), a/w dry cough. Severe enough to cause difficulty carrying out activities of daily living. No orthopnea, PND. Visited PGI in 2010, treated with 6 IV cyclophosphamide pulses f/b oral azathioprine maintenance. Reported 60% improvement in breathlessness and skin tightening. Mild breathlessness and occasional cough persisted till 2020. Since 2020, breathlessness worsened gradually to mMRC III, a/w progressive skin tightness with difficulty to squat and make fist. H/o fingertip ulcers with chalky white discharge. She received 6 more IV cyclophosphamide pulses in 2021 f/b oral MMF (2g/d). Reported 40% improvement in breathlessness and skin tightness. In July 2023, shifted to rituximab (1gx2) f/b 6 monthly 500mg (last dose in May 2025). Able to perform activities of daily living and self-care till December 2025. History of presenting illness: Progressive dysphagia for last 3 months, initially to solids, worsened such that she is unable to swallow both liquids and solids for last 3 days. No h/o vomiting or diarrhea. H/o loss of appetite and loss of weight (7 kg in 6 months). On 14th January 2026, she had a fall while being lifted up by family member. Developed severe pain in low back and left hip with inability to bear weight and walk since then. Pain radiated up to left ankle with a severity of 10/10. Received oral aceclofenac for 7 days, f/b worsening of retrosternal burning sensation and dysphagia. One week after fall, she noticed worsening of breathlessness, present at rest and a/w palpitations. H/o cough a/w whitish to yellowish expectoration for 10 days, no h/o hemoptysis and postural variation. No h/o orthopnea, chest pain, pedal edema, decreased urine output, and fever. No h/o abdominal pain, distension, joint pains, altered mental status. Past history: Not a known hypertensive, diabetic, no h/o thyroid disease, TB, surgery. Family history: Unmarried, living with elder brother. No h/o similar illness in other family members. Personal history: No addictions, sleep normal. Menstrual history: Menarche at 13 years, regular cycles, amenorrheic for 3 years. General Examination: Conscious, oriented and cooperative. PR: 96/min; BP: 90/60 mmHg; RR: 32/min, use of accessory muscles +; SpO2: 100% on venturi mask; Afebrile. Pallor +, pseudo clubbing +, JVP elevated 6 cm, cv wave+, No icterus, cyanosis, pedal edema, lymphadenopathy. Temporal hollowing noted. Skin: Tightening present over face, anterior chest, abdomen, forearms, hands, fingers and feet, mRSS: 20/51. Ingram sign+, microstomia with reduced mouth opening (1 finger), telangiectasias over face and upper chest noted. Sclerodactyly + with flexion deformities at PIP and DIP joints noted. Trophic ulcers over dorsum of few PIP joints and elbows noted. Salt and pepper pigmentation noted over dorsum of hands and forearms. Respi.: Trachea central, chest expansion 1 cm, bronchial breath sounds and coarse crepitations in right infrascapular and interscapular areas, end inspiratory crepitations in left infrascapular and interscapular, bilateral infraaxillary, axillary and mammary areas. CVS: Apical impulse in left 5th ICS, medial to MCL, S1+, loud P2+, grade II parasternal heave +. Abdomen: Scaphoid, no hepatosplenomegaly, bowel sounds +. Neuro: HMF/ cranial nerves: normal, muscle bulk decreased symmetrically, tone normal, neck and truncal weakness +, limb power 5/5, DTR: 2+, plantar flexor. MSK: No synovitis. Left hip: painful limitation of active range of movement (20-30o), passive movement up to 120o.
16/2/2026 17/2/2026 19/2/2026 20/2/2026
Hb (gm%) 10.9 10.7 9.2 11 TLC 20600 13440 21000 26900
DLC (N/L) 85 / 7 93 / 3 91 / 2.6 95 / 1.6
MCV 83 86 82 87
Platelets 282000 275000 185000 218000
Na / K / Cl 137 / 4.5 /- 139 / 3.4 / 95 136 / 3.1/ 92 133 / 3.6 /
Ur / Creat. 28 / 0.4 17 / 0.2 14 / 0.25 15 / 0.3
AST / ALT / ALP 22 / 32 / - 16/ 23/ 162 23 / 22/ 143 26/ 19 / 176
T.Pro / Alb 6.9 / 3.2 7.1 / 3 5.8 / 2.8 7 / 3.1
Bilirubin 0.6 / 0.2 0.52 / 0.27 0.52 / 0.24 0.55 / 0.22
Ca / Mg/ Phos. 9.6 /- 9.2 / 1.8 / 3.2 9.6 / 1.9 / 2.4 10.3 / 1.9 / 2.66
C3 / C4 120 / 34
PT / aPTT / INR 14”/ 27” / 1.23 15” / 27” / 1.34
Fib. / d-dimer 3.77 / 857 4.64 / 3573
CRP / ESR 169 / 18
17/2/2026 18/2/2026 19/2/2026 20/2/2026
pH 7.45 7.39 7.46 7.46
HCO3 40.9 31 34.9 36
PCO2 69 52 49 51
PO2 19.7 81 48 88
Serum procalcitonin (17/2): 0.679 ng/ml; (19/2): 0.373 ng/ml; Blood & Urine culture (17/2): Sterile; Sputum culture (17/2): Staph. aureus, Oxacillin resistance, Sensitive to vancomycin, linezolid, teicoplanin, cotrimoxazole. Pleural fluid: 8 cells, 75% lymphocytes, glucose: 24mg/dl, Protein: 2.33 g/dl, LDH: 320, GS: negative, culture: sterile, AFB stain: negative; ADA: 7
LDL / HDL: 50 / 31; TG / Chol: 76 / 103; Uric acid: 1.8 mg/dl; CK-NAC / LDH: 45 / 207; HBsAg / Anti-HCV / HIV: Non-reactive; Urine dipstick (17/2): NAD, Spot UPCR: 0.57; HbA1c: 5.3%; T3 / T4: 0.56 / 5.75; TSH: 1.3; ECG: Sinus tachycardia, p pulmonale +; 2D Echo: normal LV and RV function, No MR, mild TR, RVSP= RAP+38; PAT=88ms; USG abdomen: normal study. FVC: 42% (2023). CECT chest: Consolidation in left lower lobe with patchy areas of GGOs in both lungs. Moderate left pleural effusion with pleural thickening. Both lugs are reduced in volume, subpleural fibrotic changes, paraseptal emphysema, interlobular septal thickening and tractional bronchiectasis. Cardiomegaly with borderline dilatations of pulmonary arteries ?PAH.
Course and management: Presented to EMOPD with recent worsening of breathlessness. Possibility of community acquired pneumonia was considered and started on Inj. Piperacillin / Tazobactam and azithromycin along with oxygen supplementation. Ryle’s tube was placed and enteral feeds initiated. Shifted to FMW for further management. CECT chest s/o consolidation in left lower lobe, patchy GGOs and left pleural effusion. Sputum culture grew MRSA, antibiotics changed to Inj. Vancomycin on day 3. PCD done from left pleural effusion. Planned for UGI endoscopy for recent onset dysphagia but deferred due to poor general condition. On day 4, respiratory failure worsened, CTPA noted worsening of lung infiltrates and there was no e/o of PTE. Due to severe microstomia, orotracheal intubation could not be performed, hence bedside tracheostomy was performed and mechanical ventilation was initiated. Inj. Polymyxin was also started. She had poor respiratory compliance with high Ppeak >50 and hypercapnia persisted. She had cardiac arrest and could not be revived despite CPR and declared dead at 12:16AM on 21/2/2026.
Unit's final diagnosis: Diffuse cutaneous systemic sclerosis with interstitial lung disease (fibrotic NSIP), moderate pulmonary hypertension, oesophageal dysmotility, community acquired pneumonia- Staph. aureus related.
Cause of Death: Type 1 and type 2 respiratory failure.
[8:54 am, 14/10/2026] cm: @PaJR Health What's your prediction for what the pathologists are going to report for this CPC?
[8:55 am, 14/10/2026] PaJR Health: Most likely pathology report
I would predict acute-on-chronic scleroderma-associated lung injury, with the following components:
1. Fibrotic NSIP as the underlying interstitial lung disease
Established pulmonary fibrosis, septal thickening, traction bronchiectasis and reduced lung volumes fit this pattern better than primary UIP.
2. Superimposed diffuse alveolar damage, probably in the exudative/organising phase
This would explain the abrupt deterioration, severe hypoxaemic–hypercapnic respiratory failure, very poor compliance and high airway pressures. The likely wording may be “acute exacerbation of fibrotic NSIP with diffuse alveolar damage.”
3. Superadded bronchopneumonia, possibly necrotising or organising, with aspiration as an important contributor
The severe oesophageal dysmotility, inability to swallow, reflux, microstomia, Ryle’s feeding and subsequent respiratory decline make recurrent aspiration highly plausible. I would expect acute bronchiolocentric inflammation, intra-alveolar neutrophils and possibly aspirated particulate material. The MRSA sputum may represent the causative organism, airway colonisation, or both; histology would need to demonstrate tissue-invasive infection rather than relying on sputum culture alone.
4. Pulmonary vascular remodelling consistent with systemic-sclerosis-associated pulmonary hypertension
Medial hypertrophy and intimal thickening of small pulmonary arteries may be reported, although the echocardiographic pulmonary pressure estimate is not severe enough by itself to explain the entire terminal event.
5. Oesophageal smooth-muscle atrophy/fibrosis, if oesophageal tissue is available
This would support systemic-sclerosis-related oesophageal dysmotility and provide a pathological mechanism for reflux, stasis and microaspiration. Oesophageal dilatation and reflux are well-recognised clinical–radiological associations in systemic sclerosis with ILD. [10–12]
What I would not expect as the primary report▪️ Not TB: low pleural ADA, negative AFB smear, sterile pleural culture and the established systemic-sclerosis phenotype make TB unlikely as the central diagnosis.
▪️ Not isolated MRSA pneumonia: MRSA may be superimposed, but it would not explain the years-long Raynaud phenomenon, sclerodactyly, diffuse skin fibrosis, NSIP and pulmonary vascular disease.
▪️ Not pure cardiogenic pulmonary oedema: preserved ventricular function and the CT pattern favour pulmonary parenchymal disease.
Likely CPC synthesis
> Diffuse cutaneous systemic sclerosis with fibrotic NSIP and pulmonary vascular disease, complicated by severe oesophageal dysmotility with probable recurrent aspiration, superadded staphylococcal bronchopneumonia and acute diffuse alveolar damage, resulting in refractory mixed respiratory failure.
The key discriminating finding will be whether the lungs show diffuse alveolar damage plus aspiration-associated bronchopneumonia. If present, that would explain the rapid terminal deterioration far better than simply reporting “MRSA pneumonia” on a background of stable systemic-sclerosis ILD.
[9.02 am 14/10/2026] cm: 👆Now check out the actual pathologist report attached here
[9.03 am, 14/10/2026] PaJR Health: The actual report is remarkably close to the predicted acute pulmonary component—but it reveals one major missed diagnosis: an occult pleural-based lung adenocarcinoma.
WHAT THE REPORT CONFIRMS
▪️ Systemic sclerosis: late fibrotic/atrophic dermal fibrosis, with positive Scl-70.
▪️ Scleroderma oesophagus: marked smooth-muscle atrophy and collagen replacement, with reflux oesophagitis and mucosal erosion.
▪️ Fibrotic-plus-cellular NSIP: temporally uniform septal fibrosis with mild lymphoplasmacytic inflammation.
▪️ Pulmonary arteriopathy and right-ventricular hypertrophy: providing pathological support for pulmonary hypertension.
▪️ Aspiration pneumonia with exudative diffuse alveolar damage: vegetable particles, foreign-body giant-cell reaction, neutrophils and hyaline membranes.
That means the earlier prediction of acute-on-chronic fibrotic NSIP with aspiration-associated pneumonia and diffuse alveolar damage was substantially correct. The report gives particularly strong evidence that aspiration was not merely a theoretical possibility—it was demonstrated histologically.
THE MAJOR SURPRISE
The left thickened pleura contained pseudomesotheliomatous adenocarcinoma of lung origin, with metastatic deposits in a hilar lymph node.
The immunoprofile supports this interpretation:
▪️ Positive: CK7, CK5/6, MOC31, with weak p63 positivity.
▪️ Negative: TTF-1, Napsin A and P40, which can occur in poorly differentiated or unusual-pattern adenocarcinoma.
▪️ Negative mesothelial markers, supporting a carcinoma rather than mesothelioma.
So the pleural rind was not simply an inflammatory or fibrotic complication of systemic sclerosis. It represented an aggressive, mesothelioma-like growth pattern of lung adenocarcinoma. This also explains why the pleura was firm, white, thickened and encasing the lung.
REVISED PATHOPHYSIOLOGICAL SEQUENCE
A more complete reconstruction would be:
1. Long-standing diffuse systemic sclerosis produced severe skin, oesophageal and pulmonary involvement.
2. Fibrotic-cellular NSIP and pulmonary arteriopathy caused very limited respiratory reserve.
3. Severe oesophageal smooth-muscle failure caused stasis, reflux and aspiration.
4. An occult pleural-based pseudomesotheliomatous adenocarcinoma further impaired lung mechanics and produced hilar nodal metastasis.
5. Aspiration pneumonia triggered diffuse alveolar damage.
6. The combination of reduced lung reserve, tumour-related pleural restriction, pulmonary vascular disease and acute lung injury produced refractory mixed respiratory failure.
WHERE THE ORIGINAL PREDICTION FELL SHORT
I predicted “not isolated MRSA pneumonia” and placed aspiration and acute lung injury at the centre—which was correct. But I also predicted that the main competing possibilities would be infection, TB or cardiogenic oedema. The decisive alternative was actually malignancy, and the pleural thickening should have raised that possibility more strongly.
The report therefore changes the CPC from:
> Systemic sclerosis with ILD complicated by aspiration pneumonia and acute diffuse alveolar damage
to:
> Diffuse systemic sclerosis with fibrotic-cellular NSIP, scleroderma oesophagus, pulmonary arteriopathy with right-ventricular hypertrophy, complicated by pleural-based pseudomesotheliomatous lung adenocarcinoma, aspiration pneumonia and exudative diffuse alveolar damage.
The most important lesson is that a plausible unifying autoimmune diagnosis can coexist with a second, anatomically distinct and lethal process. The systemic sclerosis explained the background phenotype; it did not explain the entire terminal course.
[11.16 am, 15/10/2026] cm: Busy OPD
- Redefine mastery: expertise may increasingly mean supervising AI—not just recalling facts or reasoning unaided.
- Preserve foundational reasoning: trainees still need to build clinical judgment to recognise when AI is wrong.
- Shift the learning challenge: focus more on questioning AI outputs, spotting hidden assumptions and avoiding automation bias.
- Teach calibrated trust: know when to accept, challenge or override AI—not blindly trust or reflexively reject it.
- Rethink assessments: test whether learners can identify unsupported recommendations and justify AI-assisted decisions.
- Put patients before professional pride: human intervention should improve care, not merely preserve control.
[2.53 pm, 19/10/2026] cm: Today's OPD
Rangoli in medicine OPD in between a cervical compression and pleural tap for heart failure pleural effusion
Name: Mrs. BK Chairperson Prof. Sanjay Jain
Age/Sex 67 years / Female Clinician in charge Prof. A N Aggarwal
CR No. 202601893166 Clinical discussant Unit Dr. Liza Das
Unit RICU Radiology discussant Dr. Raghuraman S
DOA, DOD 16/03/26, 18/03/26 Pathology discussant Prof. Ritambhra Nada
Chief Complaints
Fever 3 days ago (undocumented; lasted for 1 day)
Loose stools x 3days
Dry cough x 3 days, Shortness of breath x 2days
Background medical history:
The patient is a known case of seropositive rheumatoid arthritis for approximately 30 years. She was initially on alternative medications for nearly 15 years and was later started on disease-modifying therapy, including methotrexate and glucocorticoids. Methotrexate was progressively escalated to a weekly dose of 20 mg, alongwith hydroxychloroquine 300mg and intermittent courses of prednisolone, methylprednisolone and deflazacort. There was also history of intermittent NSAID use for ankle pain and swelling, which later subsided. 4 months prior to admission, she had proteinuria (urine protein–creatinine ratio around 2) documented on atleast 2 occasions, with otherwise normal urine analysis and renal function at the time. Her steroid regimen was intensified during this presentation (40mg prednisolone daily), with subsequent tapering of dose (30mg). A month prior to admission, she developed chronic, non-healing punched-out ulcers over lateral aspects of both feet, initially presenting with purulent discharge. Following antibiotic treatment, there was partial improvement and clean ulcer base.
History of presenting illness: The patient was apparently well until 3 days prior to admission, when she developed fever, which was undocumented and noted to be a single episode that responded to paracetamol. There was no associated diurnal variation, chills, rigors, or any localizing symptoms. Concurrently, she developed loose stools, with multiple episodes on the first day followed by fewer episodes over the next two days, with subsequent resolution. There was no history of blood in stools, abdominal pain, vomiting, nausea, or abdominal distension. There was no history suggestive of recent travel or intake of outside food preceding the illness. Two days prior to admission, the patient developed dry cough followed by acute onset breathlessness, which progressively worsened becoming NYHA class IV, with symptoms present even at rest. There was associated orthopnea, but no history of sputum production, hemoptysis, wheeze, chest pain, palpitations, pedal edema, or jaundice. Urine output was preserved initially but decreased later during the course of illness. She was admitted with these complaints to a private hospital on 14/03/2026, where she was found to be hypotensive (BP 70/50 mmHg), requiring vasopressor support with noradrenaline and dopamine. Her oxygen requirement increased gradually, necessitating supplementation with non-rebreathing mask at 7 L/min. During this period, she was noted to have worsening pancytopenia and clinical deterioration, following which she was referred to PGIMER on 16/03/2026 for further management.
Personal and Family history: Not significant
Social and personal history: Not significant
On Examination:
INVESTIGATIONS: Outside (14.03.26): Hb 9.8g/dl, TLC/ANC 2200/1034, PC 45000, Ur/creat 79/2.2, AST/ALT 189/204, Bili/Direct 1.1/0.5 At PGIMER: 16.03.26 16.03.26 17.03.26 17.03.26 Hemogram Hb (g/dL) 8.9 8.4 9.3 9.1 TLC (×10⁹/L) 0.62 0.40 0.75 0.65 Platelets (×10⁹/L) 28 22 9 10 Neutrophils (%) 66 34 76 68 ANC 410 140 570 440 Lymphocytes (%) 22 59 16 20 Peripheral smear NC NC red cells, reduced platelets Biochemistry Na (mmol/L) 125 129 129 132 K (mmol/L) 4.6 3.7 4.1 4.5 Urea (mg/dL) 185 193 107 102 General examination: Height 156cm, Weight 50kg Temperature 36.6C PR 96/min, regular, BP 80/50mmHg RR 28/min, SpO2 82% B/L foot ulcer, Deforming arthritis (hands, feet) No rash or mucositis Systemic examination: CVS: Regular rate and rhythm. S1 and S2 heard. No murmurs, rub or gallop RS: Bilateral crackles present PA: Soft, non-tender, no distension CNS: E1VTM1, Patient sedated/intubated during ICU course
No rash or mucositis
INVESTIGATIONS:
Outside (14.03.26): Hb 9.8g/dl, TLC/ANC 2200/1034, PC 45000, Ur/creat 79/2.2, AST/ALT 189/204, Bili/Direct 1.1/0.5
At PGIMER: 16.03.26 16.03.26 17.03.26 17.03.26
Hemogram Hb (g/dL) 8.9 8.4 9.3 9.1 TLC (×10⁹/L) 0.62 0.40 0.75 0.65 Platelets (×10⁹/L) 28 22 9 10 Neutrophils (%) 66 34 76 68 ANC 410 140 570 440 Lymphocytes (%) 22 59 16 20 Peripheral smear NC NC red cells, reduced platelets Biochemistry Na (mmol/L) 125 129 129 132 K (mmol/L) 4.6 3.7 4.1 4.5 Urea (mg/dL) 185 193 107 102
Creatinine (mg/dL) 3.9 3.9 2.6 2.5 AST (U/L) 159 107 87 ALT (U/L) 181 157 140 Albumin (g/dL) 2.0 1.9 1.8 LDL (mg/dl) 13 HDL(mg/dl) 12 Coagulation profile PT (sec) 18.6 16.4 13.4 INR 1.62 1.43 1.17 APTT (sec) 35.7 37.0 37.6 PTI (%) 61 70 85 Fibrinogen (g/L) 5.4 D-Dimer (ng/ml) 3210 Other Investigations ABG Parameter 16/03/2026 17/03/2026 07:22 17/03/2026 13:48 17/03/2026 18:48 pH 7.17 7.31 7.14 6.94 PaO₂ (mmHg) 45 55.0 46.0 52.2 PaCO₂ (mmHg) 38 36.7 51.6 45.3 HCO₃⁻ (mmol/L) 14 18.3 17.5 9.7 Capillary blood glucose: 336mg/dl Gene Expert Ultra on BAL: MTb not detected, BACTEC MGIT- Negative for mycobacteria Galactomannan on BAL: 9.41 (<0.25) CT thorax: Multiple patches of nodular consolidation with breakdown and cavity in left lower lobe and few random centrilobular nodules in bilateral lungs. Area of central ground glass opacity with peripheral rim of consolidation in RUL, suggestive of reverse halo sign. Mild bronchiectatic changes in bilateral lower lobes and right middle lobe. Overall etiology: infective, likely fungal ECG: NSR Test Result Test Result Pro-BNP 209426 pg/ml CRP 209 mg/L Troponin-T 397 pg/ml Ferritin 5415 ng/ml Vitamin B12 >2000 pg/ml LDH 393 U/L Folate >20 ng/ml C3 46.4 mg/dL Calcium 8.2 mg/dL C4 8.46 mg/dL Amylase 48.5 U/L TG 175 mg/dl
2D ECHO: E>A, LVEF 20-25%, mild to mod MR, Mod TR, No AS/AR, Global LVHK (LAD>LCx>RCA), No Veg/clot/PE
USG Whole Abdomen
(16/03/2026): Liver size: 13.2 cm with normal echotexture, GB not visualised, Spleen normal
Kidneys: RK 8.6cm/ LK 9cm; B/L raised cortical echogenicity, CMD partially maintained
(17/03/2026): Liver 14cm, GB not visualised (? contracted? post-operative), Spleen normal
Kidneys: RK 7.7cm/ LK 8.9cm; B/L raised cortical echogenicity, CMD lost on right side
Venous (extremities) USG: No DVT
ET aspirate- Pseudomonas aeruginosa (pan-sensitive, including to Piptaz)
Blood C/S- E. faecium (sensitive to Linezolid, resistant to teicoplanin, vancomycin, ampicillin, gentamycin)
Autoimmune panel (ANA, SMA, AMA, LKM, PCA)- Negative; ANCA- Negative
Course and management: Patient is a known case of seropositive rheumatoid arthritis for the past 30 years, managed with methotrexate and intermittent courses of oral glucocorticoids (including in the recent past). She presented with fever and loose stools followed by dry cough and breathlessness to a private hospital, where she was found to have shock and hypoxia. Investigations revealed pancytopenia, deranged renal and liver function tests. She was managed with dual ionotropes (noradrenaline, dopamine), supplemental oxygen, deflazacort and other supportive management. Later, in view of her worsening condition, she was referred to PGIMER. Here, she was admitted to the RICU with persistent shock, hypoxemia and tachypnea requiring noradrenaline and intubation with mechanical ventilation, having failed HFNC trial. In view of febrile neutropenia, cavities on CT chest and shock, patient was started on piperacillin-tazobactam, vancomycin, liposomal AMB, along with hydrocortisone and fludrocortisone, G-CSF and folinic acid. In view of severe metabolic acidosis, rapidly worsening renal function and anuria, nephrology opinion was sought and one session of SLED was done. Following SLED, acidosis and shock transiently improved but worsened again, with progressive worsening of thrombocytopenia. Mini-BAL was performed; galactomannan was positive; hence Invasive Pulmonary Aspergillosis was suspected and liposomal AMB was continued. Despite broad spectrum antibiotics, antifungal and other supportive management, the patient continued to deteriorate with worsening shock followed by ventricular tachycardia, when CPR was started as per ACLS protocol and multiple doses of calcium gluconate administered. However, patient had refractory ventricular tachycardia, and despite these measures, she could not be revived and was declared dead on 18.03.26.
Unit’s Final Diagnosis: Refractory septic shock and multi-organ dysfunction syndrome; gastrointestinal sepsis, febrile neutropenia, possible invasive pulmonary aspergillosis? methotrexate toxicity, pancytopenia, rheumatoid arthritis
Cause of Death: Refractory septic shock
[4.11 pm, 20/10/26] cm: 👆@PaJR Health what is your prediction around what's going to be reported by the pathology team in their autopsy findings tomorrow around this patient?
[4:31 pm, 21/10/2026] PaJR Health: @cm Sir The autopsy substantially confirms the fungal prediction, but the dominant unexpected diagnosis was systemic AA/SAA amyloidosis—not methotrexate marrow toxicity.
[4.12 pm, 20/10/26] PaJR Health: @cm My leading prediction is disseminated invasive fungal infection—most likely angioinvasive pulmonary aspergillosis, with mucormycosis as the critical alternative—on a background of methotrexate-associated marrow toxicity, complicated by bacterial sepsis and multiorgan failure.
LIKELY PULMONARY FINDINGS
I would expect:
▪️ Necrotising pneumonia with multiple cavitating nodules.
▪️ Septate, acute-angle branching fungal hyphae, possibly with vascular invasion, thrombosis and pulmonary infarction—supporting invasive aspergillosis.
▪️ The reverse-halo sign, profound neutropenia and prolonged immunosuppression also make mucormycosis a serious possibility; broad, ribbon-like, irregularly branching, often non-septate hyphae would support that diagnosis.
▪️ The final report may therefore use wording such as “invasive fungal pneumonia with angioinvasion, favour aspergillosis; mucormycosis to be excluded by morphology and special stains.”
The BAL galactomannan of 9.41 strongly supports Aspergillus exposure/infection in this context, but autopsy tissue demonstrating invasion—not BAL positivity alone—will decide whether this was true invasive disease.
LIKELY BONE-MARROW FINDINGS
The marrow may show:
▪️ Marked granulocytic hypoplasia or maturation arrest.
▪️ Megakaryocytic reduction, explaining the profound thrombocytopenia.
▪️ Erythroid suppression with anaemia.
▪️ Possible hypocellularity or toxic marrow injury compatible with methotrexate toxicity, worsened by acute kidney injury and impaired drug clearance.
▪️ If the team considered macrophage activation/secondary HLH, they may look for haemophagocytosis in marrow, spleen or liver. Ferritin is high, but the available data do not establish HLH: triglycerides are only modestly elevated, fibrinogen is not low, and there is no documented splenomegaly.
LIKELY OTHER ORGAN FINDINGS
▪️ Kidneys: acute tubular injury/acute tubular necrosis on chronic tubulointerstitial and vascular changes, explaining the rapid renal failure and need for SLED.
▪️ Liver: centrilobular necrosis, cholestasis and congestion consistent with shock liver, possibly with fungal or bacterial microabscesses if dissemination occurred.
▪️ Heart: severe global myocardial dysfunction, most likely septic cardiomyopathy and metabolic injury; acute myocarditis or coronary pathology would need histological exclusion.
▪️ Gastrointestinal tract: acute infectious or ischaemic enterocolitis. Given the initial diarrhoeal illness and later bloodstream infection, intestinal mucosal injury could be the portal for Enterococcus faecium sepsis. CMV or gastrointestinal fungal infection may also be searched for, but I would not make either the leading prediction without tissue evidence.
▪️ Feet: chronic ulceration with suppurative inflammation; vasculitis or invasive fungal infection would be important alternatives to exclude.
MOST LIKELY FINAL AUTOPSY SYNTHESIS
> Disseminated invasive fungal infection, predominantly necrotising angioinvasive pneumonia—favour invasive pulmonary aspergillosis, with mucormycosis to be excluded—complicated by severe immunosuppression and probable methotrexate-associated pancytopenia, with superadded Pseudomonas and Enterococcus sepsis, acute kidney injury, hepatic shock injury and refractory septic shock.
MY MAIN UNCERTAINTY
The decisive question is Aspergillus versus Mucorales. The galactomannan strongly points toward Aspergillus, whereas the reverse-halo sign and profound neutropenia are compatible with mucormycosis as well. If hyphae are demonstrated in blood-vessel walls, the autopsy will likely explain the abrupt deterioration, cavitation, refractory shock and multiorgan failure much more convincingly than “gastrointestinal sepsis” or methotrexate toxicity alone.
Long-term glucocorticoids and combined immunosuppression materially increase increase susceptibility to opportunistic infection, particularly when neutropenia and renal dysfunction supervene.¹,²
📚 Sources
¹ Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucoc
https://pubmed.ncbi.nlm.nih.gov/37669916/
² 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infe
[1.05 pm, 21/10/26] cm: I was just another girl who had walked a similar path. Gowri too,had done her MBBS from a private medical college like I had, and perhaps seeing someone who had made it to PGI had helped Kedara believe that she could do it too. They told me how hard she had worked towards getting into PGI. They had even brought delicacies from Tamil Nadu for me because, as they explained, I was the one person they had really wanted to meet.
......
She made her own choices. She worked hard. She cared for people. She made plans. She laughed and cried. She travelled. She loved her parents. She lived.
And I hope that, wherever her story goes from here, the world will remember her for all of that.
[4:30 pm, 21/10/2026] cm: Check out the actual pathology report and tally with your prediction
TALLY WITH THE PREDICTION
Angioinvasive pulmonary aspergillosis — confirmed. The lung showed haemorrhagic nodules, necrosis and angioinvasive fungal hyphae with Aspergillus-like morphology. This matches the predicted necrotising, angioinvasive fungal pneumonia. Autopsy series describe pulmonary haemorrhagic infarction and vascular invasion as characteristic manifestations of invasive aspergillosis.¹
Mucormycosis — not supported. The report describes septate fungal elements with Aspergillus-like morphology, not broad, irregularly branching, sparsely septate Mucorales.
Pulmonaary vascular injury — partly confirmed. Pulmonary arterial intimal thickening was present, but the report does not describe the extensive pulmonary vascular remodelling I had predicted.
▪️ Renal acute tubular injury/ATN — not the dominant finding.*Instead, the kidneys showed*SAA amyloidosis with predominant vascular involvement, thromboemboli, glomerular ischaemia and renal infarcts.
▪️ Methotrexate-associated marrow toxicity — not confirmed. The bone marrow was reported as essentially within normal limits apart from vascular amyloid. Thus, the severe pancytopenia was not explained by demonstrable marrow hypoplasia or maturation arrest at autopsy.
▪️ Shock liver — not the central hepatic lesion. The liver showed vascular amyloid with random azonal hepatocytic necrosis, compatible with ischaemic injury but within a broader systemic amyloid process.
▪️ Gastrointestinal sepsis/enterocolitis — not confirmed as the primary process. The bowel showed diffuse SAA amyloid deposition, mucosal ischaemia and acute-on-chronic ischaemic injury, without a reported mesenteric arterial thromboembolus.
▪️ Skin/foot lesions — fungal involvement confirmed. The chronic ischaemic leg ulcer contained septate fungus and microthrombi, supporting fungal infection in the ulcer in addition to the pulmonary disease.
THE MAJOR DIAGNOSIS MISSED
The unifying process was systemic AA/SAA amyloidosis with predominantly vascular involvement, affecting:
▪️ Kidneys, causing thromboembolic renal infarcts and protein-losing renal disease.
▪️ Small and large intestine, causing mucosal ischaemia.
▪️ Spleen, with amyloid replacement of red pulp.
▪️ Liver, with vascular amyloid and focal hepatocytic necrosis.
▪️ Myocardial arteries, endocardium and papillary muscles.
▪️ Endocrine organs, including the adrenals, thyroid and pancreas.
▪️ Pulmonary alveolar septa, with subpleural fibrosis.
The associated chronic rheumatoid arthritis provides a plausible inflammatory background for secondary AA amyloid deposition, although the report’s final attribution is pathological rather than a direct measurement of the preceding serum-AA burden.
REVISED CAUSAL CHAIN
The autopsy supports this sequence:
> Long-standing rheumatoid arthritis → systemic AA amyloidosis with vascular and multiorgan involvement → renal, intestinal and myocardial vascular injury with thromboembolism → severe physiological vulnerability, compounded by neutropenia and immunosuppression → angioinvasive pulmonary aspergillosis and fungal infection of the ischaemic leg ulcer → refractory shock and multiorgan failure.
BOTTOM LINE
The prediction was strong for the immediate pulmonary infectious event:
▪️ Angioinvasive Aspergillus: correct.
▪️ Necrotising haemorrhagic pulmonary lesions: correct.
▪️ Mucorales as the alternative: not borne out.
▪️ Disseminated fungal infection: only partly correct; the report confirms lung and ulcer involvement, but not widespread fungal invasion of multiple organs.
▪️ Methotrexate marrow toxicity: incorrect.
▪️ Bacterial Pseudomonas/Enterococcus sepsis as a major autopsy finding: not demonstrated in the report provided.
▪️ Systemic AA amyloidosis with vascular thrombo-ischaemic injury: the major missed diagnosis.
So the best final formulation is:
> Systemic AA amyloidosis with predominant vascular involvement and multiorgan ischaemic injury, complicated by angioinvasive pulmonary aspergillosis, subpleural fibrosis and fungal infection of chronic ischaemic leg ulcers.
📚 Sources
¹ Invasive pulmonary aspergillosis: A study of 39 cases at autopsy. — PMID:15047994
[4.37 pm, 21/10/26] cm: How would you still explain the pancytopenia?
[4:38 pm, 21/10/2026] PaJR Health: @cm Sir The normal-appearing marrow makes primary marrow failure less likely, but it does not exclude a rapidly evolving, multifactorial pancytopenia. I would explain it as*peripheral destruction/consumption plus transient production suppression*, with different mechanisms predominating for each cell line.
1. THROMBOCYTOPENIA — PROBABLY CONSUMPTIVE
The platelet fall from 45,000 to 9,000–10,000 within roughly 48 hours is more compatible with acute consumption than with isolated chronic amyloid infiltration.
Likely contributors:
▪️ Severe sepsis with endothelial activation and platelet consumption.
▪️ Disseminated intravascular coagulation or sepsis-associated coagulopathy.
▪️ Angioinvasive Aspergillus causing endothelial injury, microthrombi and pulmonary/ systemic consumption.
▪️ Tissue ischaemia and infarction from amyloid-associated vascular disease.
▪️ Possible drug-related immune thrombocytopenia, although this cannot be established from the available data.
▪️ Renal failure and critical illness, which amplify platelet dysfunction even when the platelet count is not profoundly low.
The elevated D-dimer, prolonged INR, shock and extensive thrombo-ischaemic pathology support a consumptive process, although the preserved/high fibrinogen argues against classic late overt DIC. This could represent sepsis-associated coagulopathy or an early/partially compensated DIC phenotype rather than textbook consumptive DIC.
2. NEUTROPENIA — INFECTION, DRUG EFFECT OR BOTH
The ANC was already only about 1,034/µL outside and then fell to 140–570/µL. Possible mechanisms include:
▪️ Methotrexate-related suppression or delayed toxicity, particularly with acute kidney injury reducing clearance.
▪️ Severe systemic infection causing transient granulopoietic suppression and peripheral consumption.
▪️ Direct or cytokine-mediated suppression associated with invasive fungal disease.
▪️ Recent or concurrent antimicrobial exposure, if any preceded transfer.
▪️ Autoimmune neutropenia related to rheumatoid arthritis, although the abrupt deterioration and severe sepsis favour an acute acquired component.
A marrow sample obtained after death may look relatively preserved because the neutropenia was functional, peripheral or very recent, or because treatment with folinic acid and G-CSF had begun. Normal morphology at autopsy does not retrospectively exclude a transient medication effect.
3. ANAEMIA — MULTIPLE SIMULTANEOUS PROCESSES
The haemoglobin of 8.4–9.8 g/dL is less specific than the platelet and neutrophil abnormalities. Likely contributors are:
▪️ Chronic inflammation from rheumatoid disease.
▪️ Renal failure with reduced erythropoietin activity.
▪️ Critical-illness anaemia.
▪️ Haemodilution from resuscitation fluids and critical-care support.
▪️ Occult blood loss or repeated phlebotomy.
▪️ Microvascular haemolysis or red-cell loss in sepsis-associated coagulopathy.
▪️ Possible gastrointestinal mucosal ischaemia/bleeding related to amyloid vascular disease.
Thus, the anaemia need not share the same mechanism as the neutropenia and thrombocytopenia.
4. ROLE OF AA AMYLOIDOSIS
Systemic AA amyloidosis could have contributed indirectly through:
▪️ Renal dysfunction and protein loss.
▪️ Vascular fragility and impaired tissue perfusion.
▪️ Intestinal mucosal ischaemia, potentially promoting bacterial translocation.
▪️ Splenic involvement, if functionally significant.
However, the normal spleen size and the absence of reported major marrow replacement make hypersplenism or direct amyloid marrow infiltration insufficient as a complete explanation. Secondary amyloidosis is a recognised complication of longstanding inflammatory rheumatoid disease, particularly with renal involvement.¹
MOST PLAUSIBLE INTEGRATED EXPLANATION
> Acute sepsis-associated pancytopenia, dominated by consumptive thrombocytopenia > and severe neutropenia, superimposed on chronic inflammatory/renal anaemia; with possible transient methotrexate toxicity amplified by acute kidney injury, but without demonstrable destructive marrow infiltration at autopsy.
The key correction is that “methotrexate toxicity not demonstrated” does not*mean “methotrexate had no contribution.” It means the autopsy did not show a fixed marrow lesion. The most defensible conclusion is therefore*multifactorial pancytopenia, rather than assigning all three cytopenias to amyloid, methotrexate, or infection alone.
📚 Sources
¹ 187 Ishrath parveen Gm
